申请人:Dainippon Pharmaceutical Co., Ltd.
公开号:US03983239A1
公开(公告)日:1976-09-28
Hexahydro-.gamma.-carboline derivatives of the formula: ##SPC1## Wherein R.sub.1 is methyl or ethyl, and R.sub.2 is hydrogen, methyl or ethyl, with proviso that when R.sub.1 is ethyl, R.sub.2 is hydrogen, and their pharmaceutically acceptable acid addition salts, which exhibit excellent psychotropic effect, and a process for the preparation thereof.
公式为: ##SPC1## 其中R.sub.1为甲基或乙基,R.sub.2为氢、甲基或乙基,但当R.sub.1为乙基时,R.sub.2为氢。它们的药学上可接受的酸加盐具有出色的精神药物效果,并提供了一种制备方法。